What are the factors that affect the prognosis of stage 3 nasopharyngeal carcinoma?

What is the prognosis of stage 3 nasopharyngeal carcinoma? What are the factors?

Prognosis and specific treatment are as follows:

It is recommended to take Selenium Weikang chewable tablets during the treatment. Selenium Weikang can enhance the biological self-regulation effect, regulate the body's own anti-cancer factors, change the abnormal biochemical changes in cancer cells, and is of great help during radiotherapy and chemotherapy or postoperative recovery. It can improve the efficacy of drugs and control the disease.

The prognosis of nasopharyngeal carcinoma is related to the following three factors:

1. Racial differences

There are obvious racial differences in the incidence and prognosis of nasopharyngeal carcinoma. It is more common in the yellow race and less common in the white race. The severity and prognosis of nasopharyngeal carcinoma in the yellow race are worse than those in the white race.

2. Treatment methods

The choice of treatment method directly affects the survival rate of nasopharyngeal carcinoma. Currently, the best way to treat nasopharyngeal carcinoma is radiotherapy. However, many nasopharyngeal carcinoma patients cannot bear the side effects of radiotherapy and give up during the treatment process. Although radiotherapy technology is constantly improving and perfecting, it is still impossible to completely eliminate side effects. Other treatment methods are needed to enhance the patient's tolerance.

3. Early detection

The 5-year survival rate of nasopharyngeal carcinoma patients who are detected and treated early is four times that of those detected in the late stage. Early detection, early diagnosis and early treatment are important parts of nasopharyngeal carcinoma prevention and treatment. However, the early diagnosis rate of nasopharyngeal carcinoma is still not ideal. According to incomplete statistics, less than 1/2 of nasopharyngeal carcinoma patients found in outpatient clinics have early nasopharyngeal carcinoma.